(Q38912955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390602%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390602%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

main subject

visceral leishmaniasis

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390602%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

D Le Ray

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390602%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

P Van Der Stuyft

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390602%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390602%20AND%20SRC:MED&resulttype=core&format=json

Tropical Medicine and International Health

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390602%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390602%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390602%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

955-959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390602%20AND%20SRC:MED&resulttype=core&format=json

Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00959.X

Visceral leishmaniasis control: a public health perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00959.X

Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00959.X

A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00959.X

Protective efficacy of lambdacyhalothrin-impregnated bednets against Phlebotomus orientalis, the vector of visceral leishmaniasis in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00959.X

Cost-effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00959.X

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00959.X

Mucosal leishmaniasis ("espundia" Escomel, 1911).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00959.X

Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00959.X

A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00959.X

Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00959.X